Could a single drug replace the standard cocktail for C-Section bleeding?

NCT ID NCT07636421

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways to prevent heavy bleeding after a planned C-section: one drug (carbetocin) alone versus the same drug plus a slow drip of another (oxytocin). About 332 women having planned C-sections will take part. The goal is to see if the single drug works just as well, which could simplify care and reduce side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD LOSS, SURGICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical Postpartum Hemorrhage Uterine Inertia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Qassim University Medical City

    Buraidah, Al-Qassim Region, 51452, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.